Gilead’s remdesivir helped healthier Covid-19 patients:Study
Team Udayavani, May 24, 2020, 12:59 PM IST
As per a recent study, Gilead’s remdesivir, the first medicine cleared for the treatment of Covid-19, mainly benefited healthier patients who weren’t dependent on ventilators
According to the report in the New England Journal of Medicine, the drug helped patients infected with the coronavirus heal faster, allowing them to return home after about 11 days, compared to 15 days for those who were treated with a placebo.
Researchers said, “Given high mortality despite the use of remdesivir, it is clear that treatment with an antiviral drug alone is not likely to be sufficient. Future strategies should evaluate antiviral agents in combination with other therapeutic approaches or combinations of antiviral agents to continue to improve patient outcomes in Covid-19”
Researchers also said that the only group to do significantly better on remdesivir were those who were sick enough to need supplemental oxygen, but who weren’t yet on a ventilator or a heart-lung bypass machine.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
LS 2024: Yet another face-off between seasoned politicians Kota Srinivas Poojary & Jayaprakash Hegde
Wish to work for betterment of my state Odisha: UPSC 2nd rank holder Animesh Pradhan
Climate change is causing marine ‘coldwaves’ too, killing wildlife
Celebrating Vishu: A Tapestry of Traditions Across India
‘Sangh values’ run through my veins; can’t think of filling mother’s shoes: Bansuri Swaraj
MUST WATCH
Latest Additions
Injuries don’t define you: Mohammed Shami shares rehab update
Shivakumar desperately wants to become CM, says K’taka BJP chief Vijayendra
Scribe throws lapel microphone towards Sharad Pawar in Baramati; cops give clean chit
India delivers first batch of BrahMos missiles to Philippines
Air India cancels Dubai flights due to operational disruptions